For Maya Hardigan, the problem was not a lack of clinical tools, but a profound gap in how they were delivered. The maternal health crisis in the United States is well documented, but its burden is not shared equally. Black women are three times more likely to die from a pregnancy-related cause than white women, and face significantly higher rates of preterm birth and C-section [Leerink Partners, 2024]. Hardigan, a former Director of Clinical Innovation at Pfizer, saw a system failing a specific population. Her response was Mae, a digital health platform designed from the ground up to connect Black expectant mothers with culturally competent support, beginning with community-based doulas [BusinessWire, Sep 2021]. The company's recent, oversubscribed seed round, led by Jumpstart Nova, signals investor belief that this targeted, hybrid-care model can finally move the needle on entrenched disparities [BusinessWire, May 2024].
A hybrid-care model for a systemic gap
Mae's approach is built on a digital-first marketplace that aims to be more than a directory. The platform offers tools like a free birthing plan builder and 15-minute introductory consultations with doulas, acting as a low-friction entry point [Avestria Ventures, May 2024]. From there, the vision expands into a fuller suite of pregnancy and postpartum support, including digital risk-tracking and engagement tools designed to work in concert with a user's existing clinical care [BusinessWire, May 2024]. The critical distinction is the focus on whole-person, culturally attuned support, which research suggests can improve communication with providers and reduce feelings of medical dismissal that contribute to poor outcomes. The company is positioning this not as a replacement for obstetric care, but as a value-based supplemental layer.
The payer partnership pathway
For a digital health intervention to scale and prove its economic value, it must integrate with the entities that pay for care. Mae's stated strategy is to work directly with healthcare payers and state Medicaid programs, a path that aligns with its mission to serve populations most affected by disparities [BusinessWire, Sep 2021]. This is a pragmatic, if challenging, route to sustainable revenue and population-level impact. An early signal of this motion came in February 2026, when EmblemHealth announced a partnership with Mae to expand access to pregnancy and postpartum digital health support, including community-based doulas, for its Medicaid members in New York [GlobeNewswire/EmblemHealth, Feb 2026]. Such a deal validates the model's relevance for managed care organizations looking to improve outcomes and potentially lower costs associated with neonatal intensive care and maternal complications.
The company's investor syndicate reflects a deliberate focus on this mission. The table below shows the blend of specialist healthtech, diversity-focused, and impact capital that has backed Mae across its two disclosed rounds.
| Round | Date | Amount | Lead Investor(s) | Notable Participants |
|---|---|---|---|---|
| Pre-seed | Sep 2021 | $1.3M | SteelSky Ventures | Avestria Ventures, MBX Capital, Rhia Ventures, Social Starts |
| Seed | May 2024 | Undisclosed | Jumpstart Nova | Astia Fund, Impact Engine, Joyance Partners, Gratitude Railroad |
Navigating a crowded field without clinical data
The ambition is clear, but the path is fraught with the hurdles common to any digital health startup aiming for clinical integration. The most significant open question surrounds clinical evidence. While the connection between doula support and improved outcomes is supported by existing literature, Mae itself has not yet published peer-reviewed data on its specific platform's impact on key metrics like preterm birth rates, C-section rates, or patient satisfaction. In a reimbursement environment increasingly driven by proven value, generating this evidence will be a non-negotiable next step. Furthermore, the digital maternal health space is not empty.
- Evidence generation. The company's public traction is currently measured in partnerships and funding, not in published health outcomes or large-scale member enrollment figures. Proving clinical efficacy will be essential for broader payer adoption.
- Competitive context. While no direct competitors are named in sources, Mae operates in a sector with well-funded players offering general pregnancy tracking and telehealth. Its defensibility hinges on deep cultural competency and a specialized focus, but it must still convince users and payers that its offering is meaningfully different.
- Execution scale. Moving from a successful pilot with one payer to a multi-state platform requires significant operational rigor, particularly in building and managing a network of doulas that can meet demand while maintaining quality standards.
For the population Mae serves, the standard of care today is a stark reality. It often means navigating pregnancy within a healthcare system where implicit bias can lead to symptoms being dismissed and concerns being minimized. Access to a doula,a trained professional who provides physical, emotional, and informational support,is frequently an out-of-pocket expense, putting it out of reach for many. The result is that many Black women go through one of life's most significant experiences without this proven layer of advocacy and support. Mae's bet is that by building a bridge between payers, providers, and community-based doulas, it can make this support a covered benefit, transforming it from a luxury to a standard component of care for Medicaid members and others. The next twelve months will likely determine if the model can transition from a promising partnership to a replicable, evidence-backed pathway for reducing one of healthcare's most persistent inequities.
Sources
- [BusinessWire, September 2021] Maternal Health Platform Mae Launches with $1.3M | https://www.businesswire.com/news/home/20210908005314/en/Maternal-Health-Platform-Mae-Launches-with-$1.3M
- [BusinessWire, May 2024] Minority Health Focused Startup Mae Closes Oversubscribed Seed Funding Round | https://www.businesswire.com/news/home/20240507745562/en/Minority-Health-Focused-Startup-Mae-Closes-Oversubscribed-Seed-Funding-Round-to-Reduce-Maternal-Health-Disparities
- [Avestria Ventures, May 2024] Meet Mae | https://www.avestria.vc/meet-mae
- [Leerink Partners, 2024] Mae Founder & CEO Maya Hardigan | https://leerink.com/podcast/mae-founder-ceo-maya-hardigan/
- [GlobeNewswire/EmblemHealth, February 2026] EmblemHealth Partners with Mae | https://www.globenewswire.com/news-release/2026/02/04/2841235/0/en/EmblemHealth-Partners-with-Mae-to-Expand-Access-to-Pregnancy-and-Postpartum-Digital-Health-Support.html